• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性回肠造口术增加了直肠癌前切除术后直肠狭窄的发生率。

Protective ileostomy increased the incidence of rectal stenosis after anterior resection for rectal cancer.

机构信息

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong An Road, Shanghai, 200032, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

出版信息

Radiat Oncol. 2022 May 12;17(1):93. doi: 10.1186/s13014-022-02031-4.

DOI:10.1186/s13014-022-02031-4
PMID:35549964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9097119/
Abstract

BACKGROUND

In most of the views, rectal stenosis after anterior resection for rectal cancer results from pelvic radiotherapy. However, patients without receiving radiotherapy also suffer stenosis. In this study, we evaluated the factors associated with rectal stenosis after anterior rectal resection (ARR).

METHODS

We conducted a retrospective study with ARR patients who underwent neoadjuvant chemoradiotherapy and the patients without radiotherapy. Patients who received watch and wait strategy with a clinical complete response after chemoradiotherapy were also included. Patients with colonoscopy follow-up were included for further analyses; 439 patients who underwent neoadjuvant chemoradiotherapy; 545 patients who received ARR without radiotherapy and 33 patients who received watch and wait strategy. Stenosis was diagnosed when a 12-mm diameter colonoscopy could not be passed through the rectum. Univariate and multivariate logistic regression analyses were performed to identify variables associated with rectal stenosis.

RESULTS

According to the multivariate analysis in patients receiving ARR, both protective stoma and preoperative radiotherapy affected the occurrence of stenosis, with the odds ratios (ORs) of 3.375 and 2.251, respectively. According to the multivariate analysis, a preventive ileostomy was the only factor associated with stenosis both in patients receiving preoperative radiotherapy and without radiotherapy. Non-reversal ileostomy and long time between ileostomy and restoration increased the possibility of stenosis. In 33 patients who received watch and wait strategy, only one patient (3%) experienced stenosis.

CONCLUSION

Both surgery and radiotherapy are risk factors for rectal stenosis in rectal cancer patients. Compared to preoperative radiotherapy, a protective ileostomy is a more critical factor associated with rectal stenosis.

摘要

背景

在大多数观点中,直肠癌前切除术后直肠狭窄是由盆腔放疗引起的。然而,未接受放疗的患者也会出现狭窄。本研究评估了直肠癌前切除(ARR)后直肠狭窄的相关因素。

方法

我们进行了一项回顾性研究,纳入接受新辅助放化疗的 ARR 患者和未接受放疗的患者。接受放化疗后临床完全缓解的观察等待策略的患者也包括在内。对接受结肠镜随访的患者进行进一步分析;共纳入 439 例接受新辅助放化疗的患者、545 例未接受放疗的 ARR 患者和 33 例接受观察等待策略的患者。当无法通过直肠插入 12mm 直径结肠镜时诊断为狭窄。进行单因素和多因素逻辑回归分析以确定与直肠狭窄相关的变量。

结果

根据接受 ARR 的患者的多因素分析,保护性造口术和术前放疗均影响狭窄的发生,其优势比(OR)分别为 3.375 和 2.251。根据多因素分析,预防性回肠造口术是与术前放疗和未放疗患者狭窄相关的唯一因素。非反转回肠造口术和回肠造口术与重建之间的时间间隔较长增加了狭窄的可能性。在接受观察等待策略的 33 例患者中,仅有 1 例(3%)发生狭窄。

结论

手术和放疗都是直肠癌患者直肠狭窄的危险因素。与术前放疗相比,保护性造口术是与直肠狭窄更相关的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/9097119/6e57a47c0014/13014_2022_2031_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/9097119/816076c34a38/13014_2022_2031_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/9097119/6e57a47c0014/13014_2022_2031_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/9097119/816076c34a38/13014_2022_2031_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2c/9097119/6e57a47c0014/13014_2022_2031_Fig2_HTML.jpg

相似文献

1
Protective ileostomy increased the incidence of rectal stenosis after anterior resection for rectal cancer.预防性回肠造口术增加了直肠癌前切除术后直肠狭窄的发生率。
Radiat Oncol. 2022 May 12;17(1):93. doi: 10.1186/s13014-022-02031-4.
2
[Clinical features and prognosis of anastomotic leak after anterior resection for rectal cancer following neoadjuvant chemoradiotherapy].新辅助放化疗后直肠癌前切除术吻合口漏的临床特征及预后
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Jun 25;24(6):513-522. doi: 10.3760/cma.j.cn.441530-20200601-00330.
3
Protective ileostomy does not prevent anastomotic leakage after anterior resection of rectal cancer.预防性回肠造口并不能预防直肠癌前切除术后吻合口漏。
J Int Med Res. 2020 Aug;48(8):300060520946520. doi: 10.1177/0300060520946520.
4
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
5
[Clinical features and risk factors of surgical complications after intersphincteric resection for low rectal cancer following neoadjuvant chemoradiotherapy].新辅助放化疗后低位直肠癌经括约肌间切除术后手术并发症的临床特征及危险因素
Zhonghua Wai Ke Za Zhi. 2018 Dec 1;56(12):892-899. doi: 10.3760/cma.j.issn.0529-5815.2018.12.004.
6
[Protective colostomy and protective ileostomy for the prevention of anastomotic leak in patients with rectal cancer after neoadjuvant chemoradiotherapy and radical surgery].[预防性结肠造口术和预防性回肠造口术用于预防新辅助放化疗及根治性手术后直肠癌患者的吻合口漏]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Jun 25;24(6):523-529. doi: 10.3760/cma.j.cn.441530-20210304-00100.
7
Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer.在直肠癌患者中,同期放化疗及低位前切除术后,过早关闭造口会增加与造口关闭相关的并发症。
World J Surg Oncol. 2017 Apr 11;15(1):80. doi: 10.1186/s12957-017-1149-9.
8
[Effect of preservation of left colic artery on postoperative anastomotic leakage of patients with rectal cancer after neoadjuvant therapy].[保留左结肠动脉对新辅助治疗后直肠癌患者术后吻合口漏的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jun 25;22(6):566-572. doi: 10.3760/cma.j.issn.1671-0274.2019.06.010.
9
Factors preventing restoration of bowel continuity in patients with rectal cancer submitted to anterior rectal resection and protective ileostomy.接受直肠前切除术和保护性回肠造口术的直肠癌患者中,阻碍肠道连续性恢复的因素。
Rev Col Bras Cir. 2019 Jan 7;45(6):e1998. doi: 10.1590/0100-6991e-20181998.
10
Preoperative radiotherapy for patients with rectal cancer: a risk factor for non-reversal of ileostomy caused by stenosis or stiffness proximal to colorectal anastomosis.直肠癌患者的术前放疗:结直肠吻合口近端狭窄或僵硬导致回肠造口无法还纳的一个危险因素。
Oncotarget. 2017 Sep 1;8(59):100746-100753. doi: 10.18632/oncotarget.20602. eCollection 2017 Nov 21.

引用本文的文献

1
High output stoma after surgery for rectal cancer - a risk factor for low anterior resection syndrome?直肠癌手术后的高输出量造口——低位前切除综合征的一个危险因素?
BMC Gastroenterol. 2025 Jan 23;25(1):32. doi: 10.1186/s12876-025-03614-7.
2
Effects of mesenteric artery ligation level on patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a retrospective cohort study.新辅助放化疗后肠系膜动脉结扎水平对局部晚期直肠癌患者的影响:一项回顾性队列研究
Tech Coloproctol. 2024 Dec 10;29(1):13. doi: 10.1007/s10151-024-03052-9.
3
Risk factors of the low anterior resection syndrome (LARS) after ileostomy reversal in rectal cancer patient.

本文引用的文献

1
Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by Status in Patients With Locally Advanced Rectal Cancer.多中心、随机、III 期临床试验:卡培他滨和伊立替康新辅助放化疗,指导局部进展期直肠癌患者的 状态。
J Clin Oncol. 2020 Dec 20;38(36):4231-4239. doi: 10.1200/JCO.20.01932. Epub 2020 Oct 29.
2
A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study.新辅助局部进展期直肠癌中放疗剂量强化与常规分割的对比分析:一项单中心前瞻性观察研究。
Radiol Med. 2020 Oct;125(10):990-998. doi: 10.1007/s11547-020-01189-9. Epub 2020 Apr 10.
3
直肠癌患者肠造口还纳术后发生低位前切除综合征(LARS)的风险因素。
Sci Rep. 2024 Nov 16;14(1):28281. doi: 10.1038/s41598-024-79283-5.
4
Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial.保留结直肠神经的改良短程放疗联合 CAPOX 和替雷利珠单抗治疗局部进展期中低位 MSS 直肠癌(mRCAT)的前瞻性、单臂、开放标签、多中心临床研究
BMC Cancer. 2024 Oct 9;24(1):1247. doi: 10.1186/s12885-024-12994-0.
5
Clinical Outcomes of Ileostomy Closure during versus after Adjuvant Chemotherapy in Patients with Rectal Cancer.直肠癌患者辅助化疗期间与化疗后行回肠造口还纳术的临床结局。
Can J Gastroenterol Hepatol. 2024 Mar 20;2024:2410643. doi: 10.1155/2024/2410643. eCollection 2024.
6
Fibrosis signature of anastomotic margins for predicting anastomotic stenosis in rectal cancer with neoadjuvant chemoradiotherapy and sphincter-preserving surgery.新辅助放化疗联合保肛手术治疗直肠癌时,吻合口切缘纤维化特征对预测吻合口狭窄的作用
Gastroenterol Rep (Oxf). 2024 Mar 19;12:goae012. doi: 10.1093/gastro/goae012. eCollection 2024.
Cancer statistics, 2020.
癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.随机 II 期临床试验:新辅助放化疗联合诱导或巩固化疗治疗局部进展期直肠癌:CAO/ARO/AIO-12。
J Clin Oncol. 2019 Dec 1;37(34):3212-3222. doi: 10.1200/JCO.19.00308. Epub 2019 May 31.
5
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.普伐他汀逆转头颈部癌症患者的放射性皮肤和皮下纤维化:生物学驱动的 2 期临床试验 Pravacur 的结果。
Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):365-373. doi: 10.1016/j.ijrobp.2019.02.024. Epub 2019 Feb 15.
6
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.直肠癌临床实践指南(NCCN 肿瘤学版)2018 年第 2 版
J Natl Compr Canc Netw. 2018 Jul;16(7):874-901. doi: 10.6004/jnccn.2018.0061.
7
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.奥沙利铂为基础的辅助化疗 3 个月与 6 个月用于 III 期结肠癌患者:来自随机、开放标签、国际辅助持续时间评估(IDEA)法国、III 期试验的无病生存结果。
J Clin Oncol. 2018 May 20;36(15):1469-1477. doi: 10.1200/JCO.2017.76.0355. Epub 2018 Apr 5.
8
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.局部晚期直肠癌的全新辅助治疗的采用。
JAMA Oncol. 2018 Jun 14;4(6):e180071. doi: 10.1001/jamaoncol.2018.0071.
9
Genotype-driven phase I study of weekly irinotecan in combination with capecitabine-based neoadjuvant chemoradiation for locally advanced rectal cancer.基于基因型的每周伊立替康联合卡培他滨新辅助放化疗治疗局部进展期直肠癌的 I 期研究。
Radiother Oncol. 2018 Oct;129(1):143-148. doi: 10.1016/j.radonc.2017.11.026. Epub 2017 Dec 19.
10
Preoperative radiotherapy for patients with rectal cancer: a risk factor for non-reversal of ileostomy caused by stenosis or stiffness proximal to colorectal anastomosis.直肠癌患者的术前放疗:结直肠吻合口近端狭窄或僵硬导致回肠造口无法还纳的一个危险因素。
Oncotarget. 2017 Sep 1;8(59):100746-100753. doi: 10.18632/oncotarget.20602. eCollection 2017 Nov 21.